esophageal cancer
Conditions
Interventions
standard treatment group: narrow gastric tube reconstruction
experimental treatment group: whole stomach reconstruction
Sponsors
Wakayama Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with thoracic esophageal cancer whose tumor does not extend to the cervical esophagus 2) Patients who are used the stomach as a reconstructed organ and undergo reconstruction by either the posterior mediastinal route or the retrosternal route 3) Patients undergoing anastomosis in the neck 4) Patients who undergo 2-field or 3-field dissection 5) Patients aged between 18 and 85 years old at the time of enrollment 6) Patients who have given informed consent
Exclusion criteria
Exclusion criteria: 1) Patients judged to be unable to undergo either narrow gastric tube or whole stomach reconstruction due to intraoperative findings 2) Patients with serious complications (interstitial pneumonia or pulmonary fibrosis, difficult-to-control diabetes, ischemic heart disease requiring treatment, heart failure, etc.) 3) Patients with moderate or severe hepatic or renal dysfunction 4) Patients with cirrhosis or active hepatitis 5) Patients undergoing dialysis 6) Patients judged inappropriate by the attending physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of anastomotic leakage | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence rate of anastomotic stenosis Occurrence rate of pneumonia Occurrence rate of all postoperative complications Occurrence rate of reflux esophagitis QOL evaluation by EORTC QLQ-C30 and EORTC OES-18 Nutritional evaluation Amount of blood loss Postoperative hospital stay Blood flow evaluation | — |
Countries
Japan
Contacts
Public ContactJunya Kitadani
Wakayama Medical University Second Department of Surgery
Outcome results
None listed